Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Obesity
Interventions: DRUG: metformin hydrochloride|OTHER: placebo|OTHER: laboratory biomarker analysis
Sponsor: Anna Maria Storniolo
Collaborators: National Cancer Institute (NCI)